Colorectal Cancer Survival Trends in the United States From 1992 to 2018 Differ Among Persons From Five Racial and Ethnic Groups According to Stage at Diagnosis: A SEER-Based Study
Open Access
- 20 October 2022
- journal article
- research article
- Published by SAGE Publications in Cancer Control
- Vol. 29
Abstract
Introduction: Survival following colorectal cancer (CRC) has improved in the US since 1975, but there is limited information on stage-specific survival trends among racial and ethnic subgroups. Objectives: The purpose of this study was to estimate and compare trends in 1- and 5-year CRC cause-specific survival in the United States by both stage and race/ethnicity. Methods: We performed a retrospective cohort study of individuals diagnosed with CRC using the 1992-2018 Surveillance, Epidemiology and End Results (SEER) database. We estimated and compared time trends in 1- and 5-year survival for CRC stage by race/ethnicity. Results: Data from 399 220 individuals diagnosed with CRC were available. There were significant differences in stage-specific 1-year survival trends by race and ethnicity. Differences were most notable for distant stage CRC: survival probabilities increased most consistently for non-Hispanic American Indian/Alaska Native (AIAN) and Black (NHB) persons, but their trend lines were lower than those of Hispanic, and non-Hispanic Asian/Pacific Islander (API) and White (NHW) persons, whose initially greater gains appear to be slowing. Although the data do not support significant racial/ethnic differences in 5-year CRC survival trends by stage, AIAN and NHB persons have the lowest average survival probabilities for multiple CRC stages, and no racial/ethnic group has 5-year survival probabilities above 20% for distant-stage CRC. Conclusion: Although there has been an overall improvement in adjusted CRC-specific survival probabilities since 1992, AIAN and NHB persons continue to experience worse prognosis than those of other races/ethnicities. This highlights the importance of reinvigorating efforts to understand the causes of mortality in CRC, including those which may differ according to an individual’s race or ethnicity.Keywords
Funding Information
- NIH/NCI (P30 CA118100, P30 CA118100-16S4, R01 CA192967)
This publication has 51 references indexed in Scilit:
- Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive ValueClinical Cancer Research, 2012
- Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer RatesCancer Epidemiology, Biomarkers & Prevention, 2012
- Adherence to Colorectal Cancer ScreeningArchives of internal medicine (1960), 2012
- Racial Disparities in Stage-Specific Colorectal Cancer Mortality: 1960–2005American Journal of Public Health, 2010
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology, 2010
- Cancer Screening in Native Americans from the Northern PlainsAmerican Journal of Preventive Medicine, 2010
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH studyCancer Causes & Control, 2008
- Racial disparities in cancer therapyCancer, 2008
- Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidityBMC Cancer, 2007